Merck & Co. has reported non-GAAP earnings per share (EPS) for the quarter of $0.83, which excludes $0.09 of restructuring charges and merger-related expenses. Second-quarter GAAP EPS was $0.74.
The worldwide sales for the second quarter of 2009 were reported to be $5.9 billion, a decrease of 3% compared to the second quarter of 2008. Excluding the impact of foreign exchange, total revenue would have increased 3% from the second quarter of 2008.
The company’s net income for the second quarter was $1556.3m, compared with $1768.3m for the second quarter of 2008. For the first six months of 2009 the company reports worldwide sales of $11.3 billion and net income was $2981.3m.